Veradigm ROE 2010-2022 | MDRX
Current and historical return on equity (ROE) values for Veradigm (MDRX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Veradigm ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2022-12-31 | $-0.09B | $1.02B | -7.25% |
| 2022-09-30 | $0.07B | $1.18B | 5.19% |
| 2022-06-30 | $0.07B | $1.20B | 5.03% |
| 2022-03-31 | $0.15B | $1.35B | 11.08% |
| 2021-12-31 | $0.14B | $1.36B | 9.50% |
| 2021-09-30 | $0.77B | $1.42B | 50.02% |
| 2021-06-30 | $0.76B | $1.39B | 50.79% |
| 2021-03-31 | $0.73B | $1.68B | 50.03% |
| 2020-12-31 | $0.70B | $1.67B | 51.95% |
| 2020-09-30 | $-0.05B | $1.21B | -3.70% |
| 2020-06-30 | $-0.05B | $1.24B | -4.20% |
| 2020-03-31 | $-0.20B | $1.24B | -15.22% |
| 2019-12-31 | $-0.18B | $1.29B | -13.71% |
| 2019-09-30 | $0.21B | $1.28B | 14.98% |
| 2019-06-30 | $0.18B | $1.32B | 13.24% |
| 2019-03-31 | $0.40B | $1.46B | 29.92% |
| 2018-12-31 | $0.36B | $1.58B | 29.42% |
| 2018-09-30 | $0.00B | $1.12B | -0.44% |
| 2018-06-30 | $0.00B | $1.14B | 0.18% |
| 2018-03-31 | $-0.22B | $1.11B | -18.94% |
| 2017-12-31 | $-0.20B | $1.16B | -16.91% |
| 2017-09-30 | $-0.21B | $1.15B | -17.60% |
| 2017-06-30 | $-0.19B | $1.17B | -15.29% |
| 2017-03-31 | $-0.05B | $1.19B | -3.63% |
| 2016-12-31 | $-0.03B | $1.27B | -1.86% |
| 2016-09-30 | $0.00B | $1.37B | -0.14% |
| 2016-06-30 | $0.00B | $1.35B | 0.22% |
| 2016-03-31 | $0.01B | $1.39B | 0.71% |
| 2015-12-31 | $0.00B | $1.42B | -0.15% |
| 2015-09-30 | $-0.02B | $1.40B | -1.50% |
| 2015-06-30 | $-0.04B | $1.39B | -3.13% |
| 2015-03-31 | $-0.06B | $1.28B | -4.35% |
| 2014-12-31 | $-0.07B | $1.28B | -5.18% |
| 2014-09-30 | $-0.09B | $1.28B | -6.61% |
| 2014-06-30 | $-0.11B | $1.30B | -8.30% |
| 2014-03-31 | $-0.11B | $1.31B | -8.56% |
| 2013-12-31 | $-0.11B | $1.32B | -7.85% |
| 2013-09-30 | $-0.11B | $1.33B | -8.12% |
| 2013-06-30 | $-0.05B | $1.37B | -3.78% |
| 2013-03-31 | $-0.02B | $1.33B | -1.46% |
| 2012-12-31 | $0.00B | $1.28B | -0.07% |
| 2012-09-30 | $0.05B | $1.30B | 3.53% |
| 2012-06-30 | $0.06B | $1.28B | 4.15% |
| 2012-03-31 | $0.07B | $1.49B | 4.61% |
| 2011-12-31 | $0.07B | $1.48B | 5.15% |
| 2011-09-30 | $0.04B | $1.44B | 2.97% |
| 2011-06-30 | $0.02B | $1.41B | 1.72% |
| 2011-03-31 | $0.02B | $1.43B | 2.01% |
| 2010-09-30 | $0.03B | $1.37B | 6.07% |
| 2010-06-30 | $0.05B | 12.55% | |
| 2010-03-31 | $0.05B | 9.13% | |
| 2010-02-28 | $0.05B | $0.79B | 8.10% |
| 2009-09-30 | $0.04B | 7.23% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.503B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.259B | 57.58 |
| Doximity (DOCS) | United States | $11.613B | 51.53 |
| Hims & Hers Health (HIMS) | United States | $11.187B | 92.56 |
| Tempus AI (TEM) | United States | $10.529B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.158B | 0.00 |
| Hinge Health (HNGE) | United States | $4.347B | 0.00 |
| Privia Health (PRVA) | United States | $2.493B | 184.64 |
| Inspire Medical Systems (INSP) | United States | $2.355B | 34.62 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.607B | 8.49 |
| 10x Genomics (TXG) | United States | $1.516B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Schrodinger (SDGR) | United States | $1.367B | 0.00 |
| Azenta (AZTA) | United States | $1.283B | 55.96 |
| Clover Health Investments (CLOV) | United States | $1.257B | 0.00 |
| Evolent Health (EVH) | United States | $1.082B | 0.00 |
| Claritev (CTEV) | United States | $1.013B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.461B | 0.00 |
| Talkspace (TALK) | United States | $0.412B | 123.00 |
| Carlsmed (CARL) | $0.346B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.342B | 0.00 |
| TruBridge (TBRG) | United States | $0.288B | 50.50 |
| Nyxoah SA (NYXH) | Belgium | $0.239B | 0.00 |
| Outset Medical (OM) | United States | $0.221B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.188B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.92 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |